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Abstract  
Purpose: The causes of T2DM are mainly unknown, but they arise from interplay between several genetic and environmental 
factors. The I/D allele of the ACE gene has been studied in Indian population in relation to T2DM with contradictory results. 
Hence the present study was aimed to investigate whether the I/D polymorphism of ACE gene increase the susceptibility to 
T2DM.  
Material and methods: ACE gene was genotyped in 119 patients, 59 (aged matched and sex no matched) patients and 50 
(age matched and no sex matched) controls.  
Results: The Hardy Weinberg equilibrium was tested for the entire group. The χ2 (chi-square) test with Fisher’s correction 
was used to compare the genotype and allele frequency in the cases, on the one hand, and the controls, on the other . The II 
genotype occurred more frequently in North Indian population with type II diabetes mellitus patient (30%) than in the control 
(12%). The genotypic and allele frequencies differed significantly in case from control subjects (p<0.05).  
Conclusion: From the present data it was observed that in T2DM patient genotypic and allele frequencies were significantly 
deviated from Hardy-Weinberg equilibrium (p<0.05).The involvement of II genotype occurred more frequently among the case 
subjects. 
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INTRODUCTION 
 
     Patients with diabetes have a high risk of developing severe 
complications, such as diabetic nephropathy, cardiovascular disease 
and retinopathy. Type 2 diabetes is an important complication of 
hypertension and is observed in more than 30% of patients with 
hypertension[1]. The report of insertion/deletion(I/D) polymorphism of 
ACE gene was first characterized by the presence (insertion) or 
absence (deletion) of a 287 bp AluYa5 element inside  introns 16 
producing three genotype (II homozygous, ID heterozygous, DD 
homozygous), the ACE I/D polymorphism is also associated with 
overall plasma ACE level[2]. 
     Renin angiotensin system may play an important role in blood 
pressure regulation and acts as a key regulator of sodium 
homeostasis. The gene coding for Angiotensin converting Enzyme 
(ACE) regulates vascular tone through the activation of angiotensin II, 
apotent vasoconstriction[3]. Patients homozygous for the D allele are 
characterized by elevated plasma levels of  ACE compared with 
patients homozygous for the I allele, which might explain a diversity 
in the response to ACE inhibition[4]. 
     The distribution of the ACE  polymorphism varies across 
different geographical regions and ethnic groups in India and 
respectively the frequency of the I allele was found to be significantly 
higher in Dogras, Assamese and Kumaonese, while that of the D 
allele was higher in Punjabis[5]. The study conducted on south Indian 
population had found the association between the D allele (ID and 
DD genotype) of the ACE  polymorphism and diabetic nephropathy 
in south Indian type 2 diabetic patients[6]. The  ACE  insertion (I)/ 
deletion (D) polymorphism is not only effective in playing a role in 
diabetes, but also participate in cardiac complications[7]. However, 
these studies yielded conflicting results: some claiming positive 
association with ACE genotype, and others contradicting. Several 
case- control studies of diabetes have demonstrated a positive 
association of the ACE I/D polymorphism[8]. Hence the present study 
was carried out to investigate the association of I/D polymorphism 
and its role in increasing susceptibility to T2DM.  
 
MATERIAL AND METHODS 
Subject selection 
 
     The patients were recruited from those visiting the diabetic 
clinic in Department of Medicine, ERA’S Lucknow Medical College & 
Hospital, Lucknow. The study covered 109 subjects, all of whom 
were from Lucknow and the adjoining areas and belong to the Indo-
European ethnic group. Data has been collected from each patient 
on clinical variables including age, height, weight, body mass index, 
cigarette smoking, alcohol consumption and family history. Of the 
109 subjects, 59 (no age and sex matched samples) had type 2 
diabetes mellitus .Diagnosis of Diabetes was based on the physical 
and clinical examination of patients by the doctors followed by 
appropriate laboratory and other investigations. Type 2 diabetes 
mellitus is defined as a fasting plasma glucose level of more than 
126mg/Dl. The control groups consists of 50 individuals  (no age 
matched individuals)  having fasting glucose level below 110mg/Dl 
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without family history of diabetes, none of them were receiving any 
medications at the time of participation. 
 
 
 
Sample collection and DNA extraction 
 
     Five milliliters of peripheral blood was collected from all the 
subjects and anti-coagulated by collecting in EDTA blood tubes. The 
DNA was extracted by using standard Phenol-Chloroform method [9]
 
 
 
Fig 1. Lane 1, 2 & 3 showing DNA of sample and lane 4,5 & 6 showing DNA of control patients. 
 
Genotyping method for ACE I/D polymorphism 
 
     The ACE I/D polymorphism was determine by Polymerase 
chain reaction (PCR-Thermo cycler, Biometra, U.SA). The primer 
sequences used for amplification were 5’-CTG GAG ACC ACT CCC 
ATC CTT TCT-3’ (forward primer), and 5’-GAT GTC GCC ATC ACA 
TTC GTA CGA T-3’ (reverse primer)[2]. The final concentration of the 
PCR mixture was 1.5mM MgCL2, 50mM KCl, 10mM Tris-HCL (pH 
8.8), 0.1% gelatin, 1% Triton X-100, 0.3mM each of dNTPs, and 2U 
Taq DNA polymerase( Bangalore Genei, India)  in each reaction 
tube. The PCR amplification will be carried out under the following 
condition: initial denaturation at 94oC for 5 minutes, followed by 35 
cycles of denaturation at 94oC for 45 seconds, annealing at 60.4oC 
for 1.15 min , extension at 72oC for 2:30 minutes and final extension 
at 72oC for 5 minutes. The PCR products must be of 490bp for I 
allele and 190bp for D allele.  
 
Thus there are three genotypes: 
1. 490bp band (genotype II) 
2. 190bp band (genotype DD) 
3. Both band (I/D genotype)  
 
     The product was checked on 1.5% agarose gel by ethidium 
bromide staining[2].
 
 
 
Fig 2. Agarose gel picture showing PCR product for ACE polymorphism. Lane 1 & 7 is D/D genotype (490bp), lane 2, 3 & 6 is I/D genotype, lane 5 is I/I genotype (190bp) 
and lane 4 is 100bp ladder 
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Statistical Analysis 
 
     The clinical characteristics of all the subjects were expressed 
as mean and standard deviation. All the statistical analysis was 
carried out using XLSTAT 2011.2.06. The allele frequencies were 
deduced from the genotype distribution. The Hardy Weinberg 
equilibrium was tested for the entire group. The χ2 (chi-square) test 
with Fisher’s correction was used to compare the genotype and 
allele frequency in the cases, on the one hand, and the controls, on 
the other. The P value, t value and 95% CI have been calculated for 
all available clinical parameters. Two tailed alpha P value less than 
0.05 were considered significant. The odd’s ratios (OR) together with 
the 95% confidence interval (CI), comparing the allelic distribution in 
the all case and control subjects. 
 
RESULT 
 
     The general characteristics of the patients and controls, 
together with their biochemical parameters, are shown in[Table1] . Two 
groups were matched for age , but not for sex. The angiographic 
features were shown in[Table2] .. The allele frequencies and genotype 
distribution for I/D polymorphism in the ACE gene differed 
significantly between the case and the controls. The study population 
could also be divided into three groups according to genotype: 
II(n=23), ID(n=42) and DD(n=12) in patients and II(n=6), ID(n=34) 
and DD(n=10) in controls. The frequency of the I allele was 
significantly higher among the case (88%) than the controls 
(46%).Similarly, the II genotype occurred more frequently in North 
Indian population with type II diabetes mellitus patient (30%) than in 
the control (12%). The genotypic and allele frequencies differed 
significantly in case from control subjects (p<0.05). The blood 
glucose levels gave significant difference in case subjects analysed. 
 
ACE Genotyping 
 
     PCR amplification of ACE gene fragment followed by 
sequence analysis revealed Insertion/Deletion polymorphism. 
Subjects were classified according to the presence (I) or absence (D) 
of a 287 base pair insertion in intron 16 of the ACE gene into II, ID or 
DD genotypes.
 
Table 1. Clinical data of 76 North Indian type 2 diabetic patients 
 
 Observation Minimum Maximum Mean S.D. t-value P-value 95% CI 
BMI 76 17.03 37.66 25.63 4.44 2.08 <0.0001 85.02,143.27 
HBA1C 76 0.045 0.149 0.063 0.013 2.59 <0.0001 0.054,0.073 
S.Chol 76 90 283 199.5 39.4 2.11 <0.0001 204.08,216.69 
TG 76 95 764 221 137.81 2.11 <0.0001 158.88,283.29 
HDL 76 24.9 80.9 50.87 9.6 2.11 <0.0001 46.7,55.05 
LDL 76 74.4 146.3 114.14 91.49 2.11 <0.0001 85.02,143.27 
VLDL 76 19 152.8 44.22 27.55 2.11 <0.0001 31.77,56.65 
   BMI: Body mass index ;TG: Triglyceride; HDL: high density lipid; LDL: low density lipid; VLDL: very low density lipid.  
 
Table 2. Genotype distributions and allele frequency for polymorphisms in study group 
 
  Genotype Allele  
ACE gene  
 
II I/D DD I/D+DD I D 
Case Number 23 42 12 54 88 66 
 Frequency 0.3 0.55 0.15 0.7 0.57 0.42 
Controls Number 6 34 10 49 46 54 
 Frequency 0.12 0.68 0.2 0.98 0.46 0.54 
 
DISCUSSION 
 
     Angiotensin-I converting enzyme (ACE) gene is one of the most 
intensely studied genes because of the key role it plays in the rennin 
–angiotensin system (RAS). ACE gene is located on chromosome 
17q23 and consists of 26 exons and 25 introns. The insertion 
deletion (I/D) polymorphism in this gene refers to an Alu repetitive 
sequence 287 bp long, in intron 16, found in three forms: D/D and I/I 
ho-mo-zygotes and I/D hetero-zygotes. Alu insertion polymorphisms, 
like ACE I /D polymorphism, are also suit-able markers for studying 
genetic variation in human populations. They can be easily detected 
by PCR amplification and gel electrophoresis and they are stable 
markers that represent a unique evolutionary event. The distribution 
of the ACE genotypes differs between races and it is used as a 
marker in population structure analyses. 
     The ACE gene I/D polymorphism were identified in 1990 by 
Rigat and co-workers. Their study showed that the activity of 
circulating ACE depended on the insertion/deletion (I/D) 
polymorphism. Subjects with the genotype II displayed the highest 
mean activity of serum ACE, those with the genotype DD displayed 
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the lowest, and those with the genotype ID displayed the 
intermediate. Since then, it has been speculated that these 
differences in serum ACE activity associated with the ACE genotype 
might affect therapeutic response of ACE inhibitors, explaining inter 
individual variability in Cardiovascular or renal response to 
equivalent doses of ACE inhibitor.  
     The aim of our study was to look for an association between 
ACE and type 2 diabetes mellitus. We found difference between 
patients and controls in the case of allele frequency and genotype 
distribution for the I/D polymorphism of the ACE gene. The I allele 
frequency, combined frequency of I allele carriers and II genotype 
were significantly higher in the type 2 diabetes mellitus than in the 
controls. 
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